DAPANA 10

Description

DESCRIPTION:
DAPANA belongs to the category of medicines called ‘anti-diabetic’ primarily used for the management and treatment of type 2 diabetes. Type 2 diabetes is a condition that occurs when there is either less insulin or available insulin is not properly utilized by our body cells for lowering raised blood glucose. It is the most common type of diabetes, accounting for around 90% of total diabetes cases found commonly in middle-aged people. It is also called adult-onset diabetes or non-insulin-dependent diabetes mellitus (NIDDM).
DAPANA contains ‘Dapagliflozin 10mg’ a protein found in the kidney known as sodium-glucose cotransporters-2 (SGLT-2 inhibitor) that works by inhibiting the reabsorption of glucose in the body, resulting in an increase in glucose excretion through urine. The removal of excessive glucose helps to lower the blood sugar level.

Take DAPANA as prescribed. Your doctor will recommend how often you take DAPANA based on your medical condition. In some cases, you may experience urinary tract infection, low blood sugar levels (hypoglycemia), peeing more than normal, skin rash, dizziness, increased thirst, and Nausea. Most of these side effects of DAPAGLIFLOZIN do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

If you are hypersensitive to any of the components present in these medicines, please tell your doctor before taking it. DAPAGLIFLOZIN is not allowed to use in children below 18 years of age. If you are a woman who is pregnant or breastfeeding or planning to be pregnant, then tell your doctor before they prescribe this medicine to you. DAPAGLIFLOZIN, when used with diuretics, may increase the risk of dehydration, kidney problems and lower blood pressure. Let your doctor know if you are taking any other medication. Do not take or stop DAPAGLIFLOZIN if the doctor did not advise you to do so. Limit your alcohol consumption with DAPAGLIFLOZIN as alcohol may cause a rapid increase or decrease in blood sugar levels.

Uses of DAPANA

Type 2 Diabetes Mellitus
Medicinal Benefits
DAPANA contain DAPAGLIFLOZIN belongs to the anti-diabetic drug category, indicated in the treatment of type 2 diabetes or non-insulin-dependent diabetes (NIDDM). This medicine is primarily prescribed to persons whose blood sugar levels are high and not controlled by diet and exercise alone. DAPAGLIFLOZIN consists of “Dapaliflozin” a sodium-glucose cotransporter-2 (SGLT-2) inhibitor responsible for inhibiting SGLT-2 enzymes in the kidney. Thus, it prevents the reabsorption of glucose from the blood filtered through your kidney, thereby increasing the glucose excretion from your body when you urinate.
INDICATION:

Monotherapy: Dapagliflozin propanediol monohydrate is indicated for use as an adjunct to diet and exercise to improve glycemic control in adult patients with T2DM for whom metformin is inappropriate due to contraindications or intolerance.
Add-on combination: Dapagliflozin is indicated in adult patients with T2DM to improve glycemic control in combination with
• Metformin
• Sulfonylurea
• Metformin and a sulfonylurea
• Sitagliptin (alone or with metformin)
• Insulin (alone or with metformin)
Add-On Combination in Patients with Cardiovascular Risk Factors or Established Cardiovascular Disease: Dapagliflozin is indicated as an adjunct to diet, exercise, and standard-of-care therapy to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and CV risk factors or established CV disease.

Directions for Use
Take DAPAGLIFLOZIN with or without food as advised by a doctor. Swallow it as a whole with a glass of water. Do not crush, chew or break it.

CONTRAINDICATIONS:

History of serious hypersensitivity reaction to Dapagliflozin.
Severe renal impairment, end-stage renal disease, or dialysis.